Prof. Erdal Karaoz

He was born in 1963 in Izmir/TURKEY.  After graduating from Dicle University in 1986, He received Ph.D. degree in the Department of Histology&Embryology at Medical School of Gazi University in 1994.  He was in Joslin Diabetes Center of Harvard Medical School as a visiting scientist in 2005. After returning back, He established Turkey's first Stem Cell Research Center in 2006 at Kocaeli University.  He was on duty as the director of this research center and the head of the Stem Cell Department between 2007 and 2014. During these years, he published more than 60 original research papers on stem cells and cell biology in various international scientific journals. He is the author of 4 books and co-author of 6 books on Histology&Embryology and Stem Cells. He organized over 23 national and international workshops on basic stem cell technologies and IPS. He participated in over 40 research projects as a project manager or researcher in both national and international projects. Dr. Karaoz is an active member of many academic and professional institutions including European Hematology Association, European Association for Cancer Research, Turkish Society of Hematology, Society of International Cellular Medicine Society. He is also the head of Stem Cell and Cell Therapies Society. At the end of September of 2015, He started working at Liv Hospital as the head of the GMP facility. In this facility, It has been produced the cellular products such as fibroblast, chondrocytes and MSCs under FDA and GMP regulations. These cells are used in the treatment of many kind of diseases. For example, in cosmetic operations, skin anti-ageing, facial grafting, breast reconstruction, burn scars, chronic non-healing scars; for peripheral arterial disorders our cellular products are used in diseases like diabetic foot, for orthopedic disorders like articular cartilage damages, osteoarthritis and shoulder problems and also in GVHD which is a disease comprising after the transplantation of hematopoietic stem cells in some cases.